查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889209

凝血分析儀市場預測至2032年：按產品、測試類型、模式、技術、最終用戶和地區分類的全球分析

Coagulation Analyzers Market Forecasts to 2032 - Global Analysis By Product (Systems/Analyzers and Consumables), Test Type, Modality, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球凝血分析儀市場價值將達到 51.3 億美元，到 2032 年將達到 83.5 億美元，在預測期內的複合年成長率為 7.2%。

凝血分析儀是一種自動化診斷設備，用於評估血液凝固的效率和持續時間。它們透過檢測凝血因子異常情況，輔助診斷血栓症、血友病和肝臟疾病等問題。透過PT、aPTT和D-二聚體等自動化測量，這些分析儀可提供可靠的數據，用於抗凝血治療的管理，使醫護人員能夠快速做出明智的治療決策。

根據珀斯血液研究所的數據，截至 2025 年 7 月，全球男性血友病患病率預計為 1/6,000 至 1/10,000（2024 年數據），其中 A 型血友病患病率約為 1/5,000，B 型血友病患病率約為 1/30,000。

抗凝血劑使用增加

隨著越來越多的患者接受長期治療，對凝血參數進行精確監測的需求日益成長。凝血分析儀在確保安全用藥和有效治療方面發揮關鍵作用。醫院和診斷中心正擴大採用先進的分析儀來輔助制定個人化治療方案。老年人口的成長（老年人更容易發生血栓症）也進一步推動了市場擴張。因此，抗凝血治療的激增是推動凝血分析儀市場成長的主要因素。

發展中地區缺乏意識和基礎設施

許多醫療機構缺乏支援先進診斷設備所需的基礎設施。高成本和不完善的報銷政策阻礙了對現代分析設備的投資。醫護人員訓練不足也限制了現有技術的有效利用。農村和醫療資源匱乏地區往往依賴基礎診斷方法，降低了市場滲透率。因此，新興經濟體在認知度和基礎設施方面的不足持續限制經濟成長。

擴大照護現場檢測（POC​​檢測）的使用

攜帶式分析儀使臨床醫生能夠即時做出治療決策，從而改善患者預後。對分散式醫療保健日益成長的需求正在推動攜帶式分析儀在居家醫療和急診環境中的應用。技術創新正在提高即時檢測 (POC) 設備的準確性和易用性。政府和私人醫療機構正在投資 POC 解決方案，以擴大服務不足地區的醫療覆蓋範圍。這一成長趨勢為製造商拓展市場提供了重要機會。

替代產品的威脅

由於成本原因，一些醫療機構依賴人工檢測和簡易試劑盒。分子診斷和影像領域的新興技術可能會減少對傳統分析儀的依賴。成熟的替代方案通常具有使用者熟悉度高、訓練要求低的優勢。在價格敏感型市場，儘管這些替代方案的準確性較低，但仍可能受到青睞。因此，替代產品的威脅仍然是市場持續成長面臨的主要風險因素。

新冠疫情的影響：

新冠疫情擾亂了供應鏈，延誤了常規診斷流程，並影響了對分析儀的需求。然而，這場危機凸顯了血液凝固檢驗在重症病例管理中的重要性。醫院已採用快速檢測方案來監測新冠患者的凝血併發症。遠距離診斷和分散式檢查在封鎖期間備受關注。疫情後的策略現在強調韌性、數位整合以及更廣泛地普及凝血分析儀。

在預測期內，凝血酶原時間（PT）細分市場將佔據最大的市場佔有率。

由於凝血酶原時間 (PT) 在監測抗凝血治療中發揮重要作用，預計在預測期內，PT 檢測將佔據最大的市場佔有率。 PT 檢測廣泛用於評估服用Warfarin及類似藥物患者的凝血功能。其在心血管和血液系統疾病的臨床效用確保了其穩定的需求。醫院和診斷中心將 PT 檢測作為常規監測和急診護理的首選。 PT 檢測的簡單性和可靠性使其成為全球首選。

在預測期內，電化學技術領域將實現最高的複合年成長率。

由於其準確性和高效性，電化學技術領域預計將在預測期內實現最高成長率。這些分析儀能夠以極少的檢體量快速檢測凝血參數。感測器設計和微流體技術的進步提高了性能和可靠性。攜帶式電化學設備在照護現場環境中越來越受歡迎。其成本效益和擴充性使其在已開發市場和新興市場都極具吸引力。

佔比最大的地區：

由於北美擁有先進的醫療基礎設施和較高的健康意識，預計在預測期內，北美將佔據最大的市場佔有率。該地區抗凝血治療和常規凝血監測的普及率很高，而優惠的報銷政策也促進了先進分析設備的廣泛應用。主要製造商的總部設在美國，確保了北美能夠方便地取得技術創新。持續的研發投入正在鞏固該地區的技術領先地位。

年複合成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率，這主要得益於醫療基礎設施的不斷改進和患者數量的持續成長。中國和印度等國家正在大力投資診斷技術的現代化。人們對凝血障礙的認知不斷提高，推動了對先進檢測解決方案的需求。政府主導的措施和公私合營正在提升醫療服務的可近性和可負擔性。該地區龐大的人口規模和心血管疾病盛行率的不斷上升進一步增強了其成長潛力。

免費客製化服務：

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
  • 分析材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球凝血分析儀市場（依產品分類）

  • 系統/分析儀
    • 全自動系統
    • 半自動系統
    • 手動系統
    • PoC測試分析儀
  • 消耗品
    • 試劑
    • 偵測
    • 標準產品
    • 控制
    • 校對

6. 全球凝血分析儀市場（依檢驗類型分類）

  • 凝血酶原時間（PT）
  • 活化部份凝血活酵素時間（APTT）
  • 纖維蛋白原檢測
  • D-二聚體檢測
  • 抗凝血酶III試驗
  • 其他特殊血液凝固檢驗

7. 全球凝血分析儀市場（依模式分類）

  • 中央檢查室平台
  • PoC（照護現場）平台

8. 全球凝血分析儀市場（依技術分類）

  • 光學技術
  • 機械技術
  • 電化學技術
  • 其他技術

9. 全球凝血分析儀市場（依最終用戶分類）

  • 醫院
  • 臨床檢查室
  • 診斷中心
  • 研究所
  • 其他最終用戶

第10章 全球凝血分析儀市場（依地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第12章 企業概況

  • Siemens Healthineers
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • ERBA Mannheim
  • Roche Diagnostics
  • Diagnostica Stago
  • Abbott Laboratories
  • Trinity Biotech
  • Thermo Fisher Scientific
  • Helena Laboratories
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Beckman Coulter
  • Mindray Medical International
  • Horiba Medical
Product Code: SMRC32669

According to Stratistics MRC, the Global Coagulation Analyzers Market is accounted for $5.13 billion in 2025 and is expected to reach $8.35 billion by 2032 growing at a CAGR of 7.2% during the forecast period. Coagulation analyzers are automated diagnostic devices that evaluate the efficiency and timing of blood clot formation. They perform tests that identify abnormalities in clotting factors and assist in diagnosing issues like thrombosis, hemophilia, and liver-related disorders. Through automated assays such as PT, aPTT, and D-dimer, these analyzers provide reliable data for managing anticoagulant therapy, enabling healthcare professionals to make informed and rapid treatment decisions.

According to the Perth Blood Institute, as of July 2025, the prevalence of hemophilia in the male population worldwide was 1 in 6,000-10,000 in 2024, with hemophilia A affecting approximately 1 in 5,000 males and hemophilia B affecting approximately 1 in 30,000 males.

Market Dynamics:

Driver:

Increase in anticoagulant therapy use

As more patients undergo long-term treatment, the need for precise monitoring of coagulation parameters has intensified. Coagulation analyzers play a critical role in ensuring safe dosage and effective therapy outcomes. Hospitals and diagnostic centers are increasingly adopting advanced analyzers to support personalized treatment regimens. The growing elderly population, which is more prone to thrombotic conditions, further accelerates market expansion. Consequently, the surge in anticoagulant therapy use is a primary driver of growth in the coagulation analyzers market.

Restraint:

Limited awareness and infrastructure in developing regions

Many healthcare facilities lack adequate infrastructure to support advanced diagnostic equipment. High costs and insufficient reimbursement policies discourage investment in modern analyzers. Training gaps among medical professionals also hinder effective utilization of available technologies. Rural and underserved areas often rely on basic diagnostic methods, reducing market penetration. As a result, limited awareness and infrastructure continue to restrain growth in emerging economies.

Opportunity:

Increasing adoption of point-of-care (POC) testing

Portable analyzers allow clinicians to make immediate treatment decisions, improving patient outcomes. Rising demand for decentralized healthcare is driving adoption in homecare and emergency settings. Technological innovations are enhancing accuracy and usability of POC devices. Governments and private providers are investing in POC solutions to expand access in underserved regions. This growing trend represents a significant opportunity for manufacturers to broaden their market reach.

Threat:

Threat of substitute products

Some healthcare providers rely on manual testing or basic kits due to lower costs. Emerging technologies in molecular diagnostics and imaging may reduce dependence on traditional analyzers. Established substitutes often benefit from familiarity and lower training requirements. Price-sensitive markets may prefer these alternatives despite lower accuracy. Consequently, the threat of substitute products remains a notable risk for sustained market growth.

Covid-19 Impact:

The COVID-19 pandemic disrupted supply chains and delayed routine diagnostic procedures, affecting analyzer demand. However, the crisis highlighted the importance of coagulation testing in managing severe cases. Hospitals adopted rapid testing solutions to monitor clotting complications in COVID-19 patients. Remote diagnostics and decentralized testing gained traction during lockdowns. Post-pandemic strategies now emphasize resilience, digital integration, and wider accessibility of coagulation analyzers.

The prothrombin time (PT) segment is expected to be the largest during the forecast period

The prothrombin time (PT) segment is expected to account for the largest market share during the forecast period, due to its critical role in monitoring anticoagulant therapy. PT testing is widely used to assess clotting function in patients on warfarin and similar drugs. Its clinical relevance across cardiovascular and hematological conditions ensures consistent demand. Hospitals and diagnostic centers prioritize PT testing for routine monitoring and emergency care. The simplicity and reliability of PT assays make them a preferred choice globally.

The electrochemical technology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the electrochemical technology segment is predicted to witness the highest growth rate, due to its precision and efficiency. These analyzers offer rapid detection of clotting parameters with minimal sample volumes. Advances in sensor design and microfluidics are enhancing performance and reliability. Portable electrochemical devices are gaining popularity in point-of-care settings. Their cost-effectiveness and scalability make them attractive for both developed and emerging markets.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by advanced healthcare infrastructure and high awareness. The region benefits from strong adoption of anticoagulant therapies and routine coagulation monitoring. Favorable reimbursement policies support widespread use of advanced analyzers. Leading manufacturers are headquartered in the U.S., ensuring easy access to innovations. Continuous investment in R&D strengthens technological leadership in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by expanding healthcare infrastructure and rising patient volumes. Countries such as China and India are investing heavily in diagnostic modernization. Growing awareness of coagulation disorders is driving demand for advanced testing solutions. Government initiatives and public-private partnerships are fostering accessibility and affordability. The region's large population base and increasing prevalence of cardiovascular diseases amplify growth potential.

Key players in the market

Some of the key players in Coagulation Analyzers Market include Siemens H, Bio-Rad La, Sysmex Co, ERBA Man, Roche Dia, Diagnosti, Abbott Lab, Trinity Bio, Thermo Fi, Helena La, Instrumen, Nihon Koh, Beckman C, Mindray Me, and Horiba M.

Key Developments:

In November 2025, Siemens and Samsung C&T Corporation, Engineering & Construction Group have entered a strategic and long-term partnership. Grounded in mutual trust and complementary capabilities, the agreement aims to combine Samsung C&T's global engineering, procurement, and construction (EPC) expertise with Siemens' advanced technologies in automation, digitalization, electrification, and integrated infrastructure intelligence.

In July 2025, Bio-Rad Laboratories, Inc. announced the launch of four new Droplet Digital(TM) PCR (ddPCR(TM)) platforms. The newly introduced instruments include Bio-Rad's QX Continuum(TM) ddPCR system along with the QX700(TM) series of ddPCR platforms acquired as part of the company's recently completed acquisition of digital PCR developer Stilla Technologies.

Products Covered:

  • Systems/Analyzers
  • Consumables

Test Types Covered:

  • Prothrombin Time (PT)
  • Activated Partial Thromboplastin Time (APTT)
  • Fibrinogen Testing
  • D-Dimer Testing
  • Anti-Thrombin III Testing
  • Other Specialized Coagulation Tests

Modalities Covered:

  • Central Laboratory Platforms
  • Point-of-Care Platforms

Technologies Covered:

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • Other Technologies

End Users Covered:

  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Coagulation Analyzers Market, By Product

  • 5.1 Introduction
  • 5.2 Systems/Analyzers
    • 5.2.1 Automated Systems
    • 5.2.2 Semi-automated Systems
    • 5.2.3 Manual Systems
    • 5.2.4 Point-of-Care Testing Analyzers
  • 5.3 Consumables
    • 5.3.1 Reagents
    • 5.3.2 Assays
    • 5.3.3 Standards
    • 5.3.4 Controls
    • 5.3.5 Calibrations

6 Global Coagulation Analyzers Market, By Test Type

  • 6.1 Introduction
  • 6.2 Prothrombin Time (PT)
  • 6.3 Activated Partial Thromboplastin Time (APTT)
  • 6.4 Fibrinogen Testing
  • 6.5 D-Dimer Testing
  • 6.6 Anti-Thrombin III Testing
  • 6.7 Other Specialized Coagulation Tests

7 Global Coagulation Analyzers Market, By Modality

  • 7.1 Introduction
  • 7.2 Central Laboratory Platforms
  • 7.3 Point-of-Care Platforms

8 Global Coagulation Analyzers Market, By Technology

  • 8.1 Introduction
  • 8.2 Optical Technology
  • 8.3 Mechanical Technology
  • 8.4 Electrochemical Technology
  • 8.5 Other Technologies

9 Global Coagulation Analyzers Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinical Laboratories
  • 9.4 Diagnostic Centers
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Coagulation Analyzers Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Siemens Healthineers
  • 12.2 Bio-Rad Laboratories
  • 12.3 Sysmex Corporation
  • 12.4 ERBA Mannheim
  • 12.5 Roche Diagnostics
  • 12.6 Diagnostica Stago
  • 12.7 Abbott Laboratories
  • 12.8 Trinity Biotech
  • 12.9 Thermo Fisher Scientific
  • 12.10 Helena Laboratories
  • 12.11 Instrumentation Laboratory
  • 12.12 Nihon Kohden Corporation
  • 12.13 Beckman Coulter
  • 12.14 Mindray Medical International
  • 12.15 Horiba Medical

List of Tables

  • Table 1 Global Coagulation Analyzers Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Coagulation Analyzers Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Coagulation Analyzers Market Outlook, By Systems/Analyzers (2024-2032) ($MN)
  • Table 4 Global Coagulation Analyzers Market Outlook, By Automated Systems (2024-2032) ($MN)
  • Table 5 Global Coagulation Analyzers Market Outlook, By Semi-automated Systems (2024-2032) ($MN)
  • Table 6 Global Coagulation Analyzers Market Outlook, By Manual Systems (2024-2032) ($MN)
  • Table 7 Global Coagulation Analyzers Market Outlook, By Point-of-Care Testing Analyzers (2024-2032) ($MN)
  • Table 8 Global Coagulation Analyzers Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 9 Global Coagulation Analyzers Market Outlook, By Reagents (2024-2032) ($MN)
  • Table 10 Global Coagulation Analyzers Market Outlook, By Assays (2024-2032) ($MN)
  • Table 11 Global Coagulation Analyzers Market Outlook, By Standards (2024-2032) ($MN)
  • Table 12 Global Coagulation Analyzers Market Outlook, By Controls (2024-2032) ($MN)
  • Table 13 Global Coagulation Analyzers Market Outlook, By Calibrations (2024-2032) ($MN)
  • Table 14 Global Coagulation Analyzers Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 15 Global Coagulation Analyzers Market Outlook, By Prothrombin Time (PT) (2024-2032) ($MN)
  • Table 16 Global Coagulation Analyzers Market Outlook, By Activated Partial Thromboplastin Time (APTT) (2024-2032) ($MN)
  • Table 17 Global Coagulation Analyzers Market Outlook, By Fibrinogen Testing (2024-2032) ($MN)
  • Table 18 Global Coagulation Analyzers Market Outlook, By D-Dimer Testing (2024-2032) ($MN)
  • Table 19 Global Coagulation Analyzers Market Outlook, By Anti-Thrombin III Testing (2024-2032) ($MN)
  • Table 20 Global Coagulation Analyzers Market Outlook, By Other Specialized Coagulation Tests (2024-2032) ($MN)
  • Table 21 Global Coagulation Analyzers Market Outlook, By Modality (2024-2032) ($MN)
  • Table 22 Global Coagulation Analyzers Market Outlook, By Central Laboratory Platforms (2024-2032) ($MN)
  • Table 23 Global Coagulation Analyzers Market Outlook, By Point-of-Care Platforms (2024-2032) ($MN)
  • Table 24 Global Coagulation Analyzers Market Outlook, By Technology (2024-2032) ($MN)
  • Table 25 Global Coagulation Analyzers Market Outlook, By Optical Technology (2024-2032) ($MN)
  • Table 26 Global Coagulation Analyzers Market Outlook, By Mechanical Technology (2024-2032) ($MN)
  • Table 27 Global Coagulation Analyzers Market Outlook, By Electrochemical Technology (2024-2032) ($MN)
  • Table 28 Global Coagulation Analyzers Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 29 Global Coagulation Analyzers Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Coagulation Analyzers Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 31 Global Coagulation Analyzers Market Outlook, By Clinical Laboratories (2024-2032) ($MN)
  • Table 32 Global Coagulation Analyzers Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 33 Global Coagulation Analyzers Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 34 Global Coagulation Analyzers Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.